Business Development Analyst - Director - Zurich

Ort: Switzerland - Glattbrugg/Zurich

Funktion: Strategy

Senioritätslevel: Director

Ramiro Villanueva

Senior Talent Acquisition Manager

Richtlinien für Agenturen

Ihr Profil

An expert in finance and business modelling with emphasis on development stage life sciences companies, products and services


  • University degree in Biology/Chemistry/Medicine/Applied Biosciences with 8 years of work experience in relevant corporate positions within the Life Sciences Industry (Pharma/Biotech/Medtech) and/or Investment Banking. Firm understanding of the general drug discovery, development and commercialization process is a requirement
  • Strong analytical and conceptual skills. Further business and administration education (e.g. MBA) and / or first experience in Financial Analysis (e.g. CFA) would be an important additional asset
  • Interest in working in a dynamic and international work environment. Ability to communicate and work in interdisciplinary teams
  • Open and communicative personality. High client orientation and passion for close collaboration with a wide range of stakeholders. Ability to deliver high quality work under time pressure
  • Self-motivated and results-driven personality
  • Excellent oral and written communication skills in English and German

Job description:

  • The candidate will report to the Head Business Development and Licensing (BD&L)
  • BD&L as a department is embedded in the Strategy Department at the operational Headquarters in Zurich. The Strategy Department Head as a member of the Executive Committee reports directly into the CEO of Vifor Pharma and oversees other commercial and medical functions, such as Research, Pre-Clinical Development, Program Management and Regulatory Affairs. This proximity allows BD&L to cooperate closely with other departments and align with the strategic needs of the overall organization
  • The candidate will seek out and generate data required to build robust BD&L business cases (financial models) that are aligned with insights generated during the due diligence process. If the research includes external consultants or service providers, the candidate will manage such resources by himself (recruitment, briefing, definition of deliverables, etc.)
  • In performing this task, the candidate will collaborate closely with stakeholders and data providers of adjacent departments, namely Market Analytics, Medical Affairs, Regulatory, Market Access and Clinical Development. Important aspects to consider for the business case development are:
    • Epidemiology and patient flow
    • Standard of care
    • Medical need
    • Competitive landscape
    • Target product profile
    • Pricing
    • Uptake and market share
    • Commercialization costs
    • Etc.
  • The candidate will generate content for presentations to the Executive Committee and the Board of Directors of Vifor Pharma
  • The candidate will be considered the “data owner” in regards to BD&L business cases and will assist in the transition of those business cases to Corporate Finance and Project Management once a deal is closed
  • As a secondary objective, the candidate will support efforts to identify new companies, new products and services and ultimately new investment ideas that are in alignment with the strategic needs of the Vifor Pharma Group
  • The candidate will be part of a BD&L department and participate with his other team members in the early evaluation and project triage of newly identified opportunities (deal flow)

Über uns

Die Vifor Pharma Gruppe ist ein globales Spezialitäten-Pharmaunternehmen. Sie hat sich zum Ziel gesetzt, globale Marktführerin in den Bereichen Eisenmangel, Nephrologie und kardiorenale Therapien zu werden. Das Unternehmen ist der bevorzugte Partner für Pharmaprodukte und innovative, patientenorientierte Lösungen. Die Vifor Pharma Gruppe will Patienten mit schweren und chronischen Krankheiten auf der ganzen Welt dabei helfen, ein Leben in besserer Gesundheit zu führen. Das Unternehmen entwickelt, produziert und vermarktet pharmazeutische Produkte für eine optimale Patientenversorgung. Die Vifor Pharma Gruppe nimmt in allen ihren Kerngeschäften eine führende Position ein und besteht aus folgenden Unternehmen: Vifor Pharma, Vifor Fresenius Medical Care Renal Pharma (ein gemeinsam mit Fresenius Medical Care geführtes Unternehmen); und OM Pharma.

Die Vifor Pharma Gruppe hat ihren Hauptsitz in der Schweiz und ist an der Schweizer Börse (SIX Swiss Exchange, VIFN, ISIN: CH0364749348) kotiert.

Weitere Informationen finden Sie auf

Inhalt ein-/ausblenden

Xing Send to a friend

Richtlinien für Agenturen